What is the recommended treatment for an Enterococcus faecium urinary tract infection (UTI) that is sensitive to ampicillin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Ampicillin-Susceptible Enterococcus faecium UTI

Ampicillin is the definitive drug of choice for ampicillin-susceptible Enterococcus faecium urinary tract infections. 1, 2

Recommended Treatment Regimen

For Uncomplicated UTI (Oral Therapy)

  • Amoxicillin 500 mg orally every 8 hours for 7 days is the preferred first-line oral therapy, achieving clinical cure rates of 88.1% and microbiological eradication rates of 86% 2, 3
  • Ampicillin 500 mg orally every 8 hours for 7 days is an equivalent alternative with similar efficacy 2, 3

For Complicated UTI or Hospitalized Patients (IV Therapy)

  • High-dose ampicillin 2 g IV every 4-6 hours (18-30 g daily in divided doses) is recommended to achieve sufficient urinary concentrations 2, 4
  • The FDA label specifically indicates ampicillin for urinary tract infections caused by susceptible organisms 4

Catheter-Associated UTI Considerations

  • Remove the indwelling catheter if clinically feasible, as catheter retention is strongly associated with treatment failure 1
  • If catheter removal is not possible, consider antibiotic lock therapy in addition to systemic ampicillin therapy 1
  • Treatment duration should be 7-14 days for catheter-associated enterococcal UTI 1

Critical Clinical Decision Points

Confirm True Infection vs. Colonization

  • Do not treat asymptomatic bacteriuria, which is extremely common in catheterized patients and treatment fosters antimicrobial resistance 1, 3
  • Ensure the patient has symptomatic infection with fever, dysuria, urgency, or systemic signs before initiating therapy 1

Monitor for Complicated Infection

  • Evaluate for signs of upper tract involvement including fever, rigors, flank pain, or delirium that would warrant longer therapy 1
  • If persistent bacteremia occurs despite appropriate therapy, obtain transesophageal echocardiography to evaluate for endocarditis 1

Alternative Oral Agents (If Ampicillin Cannot Be Used)

  • Nitrofurantoin 100 mg orally every 6 hours for 7 days has excellent activity against E. faecium with resistance rates below 6% 2, 3, 5
  • Fosfomycin 3 g orally as a single dose is FDA-approved specifically for E. faecalis UTI and provides convenient single-dose therapy for uncomplicated infections 2, 3, 5

Common Pitfalls to Avoid

  • Do not use fluoroquinolones despite reported susceptibility, as clinical outcomes are poor and resistance rates are high (46-47% for ciprofloxacin/levofloxacin) 2, 3
  • Do not ignore the catheter - failure to address the indwelling catheter significantly increases treatment failure rates 1
  • Do not assume resistance based solely on species - E. faecium can be ampicillin-susceptible, particularly clade B and A2 strains, which differ from the typically resistant clade A1 hospital-associated strains 6

Unique Pharmacokinetic Advantage

  • High urinary concentrations of ampicillin can overcome elevated MICs, making it effective even when in vitro susceptibility testing suggests borderline resistance 2, 7
  • This pharmacokinetic property is specific to urinary tract infections and does not apply to other infection sites 7

References

Guideline

Catheter-Associated Urinary Tract Infections Due to Enterococcus faecalis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Enterococcus faecalis in Urine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Best Oral Antibiotic for Uncomplicated Pansensitive Enterococcus faecalis UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Aminopenicillins for treatment of ampicillin-resistant enterococcal urinary tract infections.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2022

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.